# ZIPRASIDONE MESYLATE
> **ANDA216091** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-09-15
## Drug
- **FDA Application Number:** ANDA216091
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ZIPRASIDONE MESYLATE
- **Generic name:** ZIPRASIDONE MESYLATE
- **Active ingredients:** ZIPRASIDONE MESYLATE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2022-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216091)
---
*AI Analytics · CC0 1.0*